ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,561Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 117

$634K Total Retail Price of All Prescriptions

Rank: 22 out of 117

478 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 478 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

11% of this provider’s 478 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 9,330 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LISINOPRIL 500 420 1 4
HYDROCHLOROTHIAZIDE 438 411 2 13
PRAVASTATIN SODIUM 391 331 3 29
FUROSEMIDE 376 306 4 3
METFORMIN HCL 354 286 5 11
ATENOLOL 351 324 6 20
SIMVASTATIN 339 283 7 1
AMLODIPINE BESYLATE 336 299 8 5
OMEPRAZOLE 262 209 9 6
METOPROLOL TARTRATE 259 229 10 8
LEVOTHYROXINE SODIUM 254 219 11 2
HYDROCODONE-ACETAMINOPHEN 224 115 S3 12 7
WARFARIN SODIUM 205 202 13 9
LOSARTAN POTASSIUM 178 165 14 23
ALLOPURINOL 160 133 15 48
GABAPENTIN 158 120 16 16
POTASSIUM CHLORIDE 142 111 17 17
TRAMADOL HCL 141 124 18 18
GLIMEPIRIDE 133 102 19 69
LANTUS 120 113 20 43
ZOLPIDEM TARTRATE 111 64 21 27
ATORVASTATIN CALCIUM 99 98 22 15
ACETAMINOPHEN-CODEINE 98 63 S3 23 76
FENOFIBRATE 98 84 23 84
SPIRONOLACTONE 94 60 25 53
MELOXICAM 91 74 26 61
PREDNISONE 90 76 27 49
DONEPEZIL HCL 89 89 28 10
GEMFIBROZIL 86 65 29 186
PANTOPRAZOLE SODIUM 86 70 29 26
GLYBURIDE 85 85 R 31 88
ALENDRONATE SODIUM 82 78 32 21
TRIAMTERENE-HCTZ 79 62 33 74
PROAIR HFA 75 30 34 56
INSULIN SYRINGE 73 54 35 95
METOPROLOL SUCCINATE 71 68 36 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 58 37 72
FENTANYL 69 21 S2 38 41
METFORMIN HCL ER 69 51 38 97
ENALAPRIL MALEATE 65 65 40 33
DIOVAN 64 61 41 31
CITALOPRAM HBR 62 61 42 19
RANITIDINE HCL 59 29 43 58
KLOR-CON M20 59 48 43 34
HYDRALAZINE HCL 59 58 43 54
SYMBICORT 58 49 46 168
SYNTHROID 58 55 46 102
TAMSULOSIN HCL 54 45 48 28
ADVAIR DISKUS 54 40 48 51
BETAMETHASONE DIPROPIONATE 51 27 50 263
CRESTOR 51 40 50 50
KLOR-CON M10 50 50 52 89
ISOSORBIDE MONONITRATE ER 50 47 52 52
DILTIAZEM 24HR ER 50 49 52 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 24, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.